Monoclonal antibodies can save lives of sick COVID-19 patients, study finds
Monoclonal antibodies can save lives of sick COVID-19 patients, study finds
Researchers at Baylor Scott and White that conducted trials on monoclonal antibodies found the antibodies can not only prevent severe illness but also saves lives.
DALLAS - Researchers at Baylor Scott and White that conducted trials on monoclonal antibodies found the antibodies can not only prevent severe illness but also saves lives.
The study found that people with mild to moderate illness who get the monoclonal antibody treatment early have very good outcomes when it comes to avoiding severe illness or dying from COVID-19.